Integral Investment Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Integral Investment Advisors’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4K	Hold	10,000	–	–	﹤0.01%	181
2026 Q1	$11.9K	Hold	10,000	–	–	﹤0.01%	174
2025 Q4	$20.2K	Buy	+10,000	New	+$21.5K	0.01%	176

Other funds holding MIST

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

BRG

Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return

SAM

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Integral Investment Advisors's MIST Position: Q2 2026 in Review

Integral Investment Advisors held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 10,000 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #181.

Integral Investment Advisors first reported a position in MIST in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.2K in Q4 2025. 5 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Integral Investment Advisors held 10,000 shares of Milestone Pharmaceuticals worth $13.4K as of Q2 2026.
Integral Investment Advisors left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Integral Investment Advisors's portfolio in Q2 2026, its #181 holding.
Integral Investment Advisors first reported a position in Milestone Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
Integral Investment Advisors's Milestone Pharmaceuticals position peaked at $20.2K in Q4 2025.
5 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.